Marand's Think!EHR Platform Wins EU SME Instrument of Horizon 2020 Grant

The European Commission has published a list of the small and medium-sized enterprises (SMEs) that will be first to benefit from its new €3 billion SME Instrument. 155 SMEs from 21 countries will each receive €50,000 to finance feasibility studies for their projects. After that, their projects may be considered for further financial support from the Commission worth up to €2.5 million.

Máire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science, said: "Innovative SMEs will help get the European economy back on track, creating lasting employment and great products and services. This new instrument is aimed at projects that are truly innovative, with a strong business opportunity and a solid concept to bring them to the market.

Tomaz Gornik, Marand CEO said: "We are very proud to have been selected as recipients of the SME Instrument grant. It will accelerate our plans to build a global ecosystem of innovative partners. Think!EHR Platform's open APIs allow other SMEs to quickly build state of the art solutions while vendor-neutral data models provide the benefits of open data to their customers."

The response to the first round of selection was remarkable, with 2662 proposals from the countries participating in Horizon 2020 (IP/14/876). Evaluation by independent experts showed that 317 of the proposals met the evaluation standard. Of those, 155, or 49%, have been selected for funding.

The selected SMEs are in a good position to succeed in the second phase of the programme, in which applicants can receive between €0.5 and 2.5 million to finance innovation activities such as demonstration, testing, piloting, scaling up, and miniaturisation. The beneficiaries will also develop their business plan.

The SME instrument was launched under Horizon 2020, the EU's new €80 billion research funding programme, to help innovative small firms get innovative projects from the lab to the market. SMEs from EU Member States or countries associated to Horizon 2020 can apply.

Think!EHR Platform™ is a health data platform designed for real-time, transactional health data storage, query, retrieve and exchange based on vendor-neutral open data standards including openEHR.

For further information, please visit:
http://www.marand-think.com

Related news articles:

About Marand
Marand is a solution provider in healthcare offering products including Think!Med EHR Platform and Think!Med Clinical™. Solution are based on state of the art technology and industry standards such as openEHR, IHE and HL7. Marand has partnership agreements with a range of companies including Capsule Tech, IBM, Ocean Informatics, Oracle, Tiani Spirit and others.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...